نتائج البحث - Hideyuki Hyogo

تنقيح النتائج
  1. 1
    Leptin Promotes Biliary Cholesterol Elimination during Weight Loss in ob/ob Mice by Regulating the Enterohepatic Circulation of Bile Salts

    Leptin Promotes Biliary Cholesterol Elimination during Weight Loss in ob/ob Mice by Regulating the Enterohepatic Circulation of Bile Salts حسب Hideyuki Hyogo, Suheeta Roy, Beverly Paigen, David E. Cohen

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Deletion of angiotensin II type I receptor reduces hepatic steatosis

    Deletion of angiotensin II type I receptor reduces hepatic steatosis حسب Yoshitaka Nabeshima, Susumu Tazuma, Keishi Kanno, Hideyuki Hyogo, Kazuaki Chayama

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid

    Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid حسب Aya Kanbara, Yoshisuke Miura, Hideyuki Hyogo, Kazuaki Chayama, Issei Seyama

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property

    Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property حسب Hideyuki Hyogo, Sho‐ichi Yamagishi, Sayaka Maeda, Yuki Kimura, Tomokazu Ishitobi, Kazuaki Chayama

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study

    Efficacy of pitavastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study حسب Hideyuki Hyogo, Tadashi Ikegami, Katsutoshi Tokushige, Etsuko Hashimoto, Kazuo Inui, Yasushi Matsuzaki, Hironori Tokumo, Fumiaki Hino, Susumu Tazuma

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Microvascular Hyperpermeability in Caveolin-1 (−/−) Knock-out Mice

    Microvascular Hyperpermeability in Caveolin-1 (−/−) Knock-out Mice حسب William Schubert, Philippe G. Frank, Scott E. Woodman, Hideyuki Hyogo, David E. Cohen, Chi-Wing Chow, Michael P. Lisanti

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

    Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease حسب Kikuko Hotta, Masato Yoneda, Hideyuki Hyogo, Hidenori Ochi, Seiho Mizusawa, Takato Ueno, Kazuaki Chayama, Atsushi Nakajima, Kazuwa Nakao, Akihiro Sekine

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

    Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis حسب Kento Imajo, Masato Yoneda, Takaomi Kessoku, Yuji Ogawa, Shin Maeda, Yoshio Sumida, Hideyuki Hyogo, Yuichiro Eguchi, Koichiro Wada, Atsushi Nakajima

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease

    High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease حسب Tamar H. Taddei, James Dziura, Shu Chen, Ruhua Yang, Hideyuki Hyogo, Cameron Sullards, David E. Cohen, Gregory M. Pastores, Pramod K. Mistry

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Association of polymorphisms in <i>GCKR</i> and <i>TRIB1</i> with nonalcoholic fatty liver disease and metabolic syndrome traits

    Association of polymorphisms in <i>GCKR</i> and <i>TRIB1</i> with nonalcoholic fatty liver disease and metabolic syndrome traits حسب Aya Kitamoto, Takuya Kitamoto, Takahiro Nakamura, Yuji Ogawa, Masato Yoneda, Hideyuki Hyogo, Hidenori Ochi, Seiho Mizusawa, Takato Ueno, Kazuwa Nakao, Akihiro Sekine, Kazuaki Chayama, Atsushi Nakajima, Kikuko Hotta

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin

    Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin حسب Yuji Ogawa, Kento Imajo, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Shingo Kato, Koji Fujita, Masato Yoneda, Satoru Saito, Yusuke Saigusa, Hideyuki Hyogo, Yoshio Sumida, Yoshito Itoh, Kosei Eguchi, Takeharu Yamanaka, Koichiro Wada, Atsushi Nakajima

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

    Glycemic Variability Is an Independent Predictive Factor for Development of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease حسب Motoi Hashiba, Masafumi Ono, Hideyuki Hyogo, Yukio Ikeda, K. Masuda, Reiko Yoshioka, Yoichi Ishikawa, Yuri Nagata, Kensuke Munekage, Tsunehiro Ochi, Akira Hirose, Yasuko Nozaki-Fujimura, Shuhei Noguchi, Nobuto Okamoto, Kazuaki Chayama, Narufumi Suganuma, Toshiji Saibara

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

    Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population حسب Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study

    LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicent... حسب Kento Imajo, Hideyuki Hyogo, Masato Yoneda, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Yuji Ogawa, Masataka Taguri, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Hiroyuki Kirikoshi, Satoru Saito, Yoshio Sumida, Masafumi Ono, Koichiro Wada, Atsushi Nakajima, Yuichiro Eguchi

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

    Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography حسب Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo, Yoshio Sumida, Masafumi Ono, Yuichiro Eguchi, Tomio Inoue, Takeharu Yamanaka, Koichiro Wada, Satoru Saito, Atsushi Nakajima

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis

    Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis حسب Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Makoto Yamada, Kojiroh Mori, Saiyu Tanaka, Tomohiro Maekawa, Yusuke Ebisutani, Akiko Yamamoto, Shinji Takamatsu, Masashi Yoneda, Norifumi Kawada, Kazuaki Chayama, Toshiji Saibara, Tetsuo Takehara, Eiji Miyoshi

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring

    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring حسب Fumi Honda, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Aikata, Kana Daijo, Yuji Teraoka, Yuki Inagaki, Kei Morio, Tomoki Kobayashi, Takashi Nakahara, Yuko Nagaoki, Tomokazu Kawaoka, Masayasu Yoneda, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hidenori Ochi, Kazuaki Chayama

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis

    Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis حسب Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic

    FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic حسب Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice

    Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice حسب Sandra K. Erickson, Steven R. Lear, Sean Deane, Sandrine Dubrac, Sandra Huling, Lien Nguyen, Jaya Bollineni, Sarah Shefer, Hideyuki Hyogo, David E. Cohen, Benjamin L. Shneider, Ephraim Sehayek, M Ananthanarayanan, Natarajan Balasubramaniyan, Fredrick J. Suchy, Ashok K. Batta, Gerald Salen

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: